0001209191-14-070835.txt : 20141124
0001209191-14-070835.hdr.sgml : 20141124
20141124165750
ACCESSION NUMBER: 0001209191-14-070835
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141120
FILED AS OF DATE: 20141124
DATE AS OF CHANGE: 20141124
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AUXILIUM PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001182129
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 233016883
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 640 LEE ROAD
CITY: CHESTERBROOK
STATE: PA
ZIP: 19087
BUSINESS PHONE: 484 321 5900
MAIL ADDRESS:
STREET 1: 640 LEE ROAD
CITY: CHESTERBROOK
STATE: PA
ZIP: 19087
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tursi James Patrick
CENTRAL INDEX KEY: 0001527710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36628
FILM NUMBER: 141246913
MAIL ADDRESS:
STREET 1: 640 LEE ROAD
CITY: CHESTERBROOK
STATE: PA
ZIP: 19087
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-11-20
0
0001182129
AUXILIUM PHARMACEUTICALS INC
AUXL
0001527710
Tursi James Patrick
C/O AUXILIUM PHARMACEUTICALS, INC.
640 LEE ROAD
CHESTERBROOK
PA
19087
0
1
0
0
Chief Medical Officer
Common Stock
2014-11-20
4
M
0
37500
14.10
A
76203
D
Common Stock
2014-11-20
4
M
0
28500
19.51
A
104703
D
Common Stock
2014-11-21
4
M
0
5000
22.04
A
109703
D
Common Stock
2014-11-20
4
S
0
6200
32.9441
D
103503
D
Common Stock
2014-11-20
4
S
0
59800
33.1751
D
43703
D
Common Stock
2014-11-21
4
S
0
3648
33.446
D
40055
D
Common Stock
2014-11-21
4
S
0
5000
33.4863
D
35055
D
Nonqualified Stock Option (Right to Buy)
14.10
2014-11-20
4
M
0
37500
0.00
D
2012-08-08
2021-08-08
Common Stock
37500
12500
D
Nonqualified Stock Option (Right to Buy)
19.51
2014-11-20
4
M
0
28500
0.00
D
2013-02-14
2022-02-13
Common Stock
28500
28500
D
Nonqualified Stock Option (Right to Buy)
22.04
2014-11-21
4
M
0
5000
0.00
D
2012-02-17
2021-02-17
Common Stock
5000
4750
D
Includes 498 shares acquired under the Auxilium Pharmaceuticals, Inc. 2006 Employee Stock Purchase Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.925 to $32.97, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.10 to $33.32, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.40 to $33.525, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.38 to $33.53, inclusive.
/s/ Michael J. Purvis, as attorney-in-fact on behalf of James P. Tursi, M.D.
2014-11-24